Breast Cancer Management in North Carolina: Updates for 2020 SPOC

Dr. Emily Ray, from the UNC Lineberger Breast Oncology group, will describe relevant updates in systemic therapy for breast cancers for health care providers throughout the state of North Carolina.

Target Audience

These courses are intended for medical, radiation, and surgical oncologists, hematologists, advanced practice nurses, physician assistants, radiologic technologists, researchers, pharmacists, trainees, and others who are interested in care of patients with cancer in North Carolina.

Learning Objectives

Recognize the options for adjuvant therapy in early stage HER2+ breast cancer

Describe the role of genomic assays in determining adjuvant treatment for early stage hormone receptor-positive (HR+) breast cancer

Define the options for treating metastatic HER2+ breast cancer

Course summary
Available credit: 
  • 1.00 Participation
Course opens: 
Course expires: 
Photo of Emily Ray, MD, MPH 

Emily Ray, MD, MPH

Assistant Professor
Department of Medicine
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill


Presenter Disclosure Information

Emily Ray, MD, MPH, has no relevant financial relationships with commercial interests as defined by the ACCME.


This Non-Credit Course does NOT have accreditation for continuing education credits.

The course offers only general participation certificates.

Available Credit

  • 1.00 Participation
Please login or register to take this course.